Literature DB >> 19858224

Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations.

Kristian Unger1, Johannes Wienberg, Andrew Riches, Ludwig Hieber, Axel Walch, Andreas Brown, Patricia C M O'Brien, Cäcilia Briscoe, Lindsey Gray, Elke Rodriguez, Gerhard Jackl, Jeroen Knijnenburg, Giovanni Tallini, Malcolm Ferguson-Smith, Horst Zitzelsberger.   

Abstract

Chromosomal copy number alterations and chromosomal rearrangements are frequent mutations in human cancer. Unlike copy number alterations, little is known about the role and occurrence of chromosomal rearrangements in breast cancer. This may be due to the fact that chromosome-based breakpoint analysis is widely restricted to cultured cells. In order to identify gene rearrangements in breast cancer, we studied the chromosomal breakpoints in radiation-transformed epithelial breast cell lines using a high-resolution array-based approach using 1 Mb bacterial artificial chromosome (BAC) arrays. The breakpoints were further narrowed down by fluorescence in situ hybridisation (FISH) with clones from the 32 k BAC library. The analysis of the cell lines B42-11 and B42-16 revealed rearrangements of chromosomes 7, 8, 10 and 12. We identified the genes Has2, Grid1, Ret, Cpm, Tbx3, Tbx5, Tuba1a, Wnt1 and Arf3 within the breakpoint regions. Quantitative RT-PCR showed a deregulated expression of all of these candidate genes except for Tbx5 and Tbx3. This is the first study demonstrating gene rearrangements and their deregulated mRNA expression in radiation-transformed breast cells. Since the gene rearrangements occurred in the transformed and tumourigenic cell lines only, it is likely that these were generated in conjunction with malignant transformation of the epithelial breast cells and therefore might reflect early molecular events in breast carcinogenesis. Initial studies indicate that these gene alterations are also found in sporadic breast cancers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19858224     DOI: 10.1677/ERC-09-0065

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  14 in total

1.  Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1).

Authors:  Berit Bernert; Helena Porsch; Paraskevi Heldin
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

2.  Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer.

Authors:  Zachary E Stine; David M McGaughey; Seneca L Bessling; Shengchao Li; Andrew S McCallion
Journal:  Hum Mol Genet       Date:  2011-07-07       Impact factor: 6.150

3.  Co-segregation of trichorhinophalangeal syndrome with a t(8;13)(q23.3;q21.31) familial translocation that appears to increase TRPS1 gene expression.

Authors:  Dezső David; Bárbara Marques; Cristina Ferreira; Carlos Araújo; Luís Vieira; Gabriela Soares; Cristina Dias; Maximina Pinto
Journal:  Hum Genet       Date:  2013-07-09       Impact factor: 4.132

Review 4.  Ret Receptor Has Distinct Alterations and Functions in Breast Cancer.

Authors:  Albana Gattelli; Nancy E Hynes; Ignacio E Schor; Sabrina A Vallone
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-02-21       Impact factor: 2.673

5.  Chromosomal rearrangements in post-Chernobyl papillary thyroid carcinomas: evaluation by spectral karyotyping and automated interphase FISH.

Authors:  Ludwig Hieber; Reinhard Huber; Verena Bauer; Quirin Schäffner; Herbert Braselmann; Geraldine Thomas; Tatjana Bogdanova; Horst Zitzelsberger
Journal:  J Biomed Biotechnol       Date:  2011-03-13

6.  Delineating chromosomal breakpoints in radiation-induced papillary thyroid cancer.

Authors:  Heinz-Ulrich G Weier; Yuko Ito; Johnson Kwan; Jan Smida; Jingly F Weier; Ludwig Hieber; Chun-Mei Lu; Lars Lehmann; Mei Wang; Haig J Kassabian; Hui Zeng; Benjamin O'Brien
Journal:  Genes (Basel)       Date:  2011-09-01       Impact factor: 4.096

7.  c-MYC is a radiosensitive locus in human breast cells.

Authors:  M A Wade; N J Sunter; S E Fordham; A Long; D Masic; L J Russell; C J Harrison; V Rand; C Elstob; N Bown; D Rowe; C Lowe; G Cuthbert; S Bennett; S Crosier; C M Bacon; K Onel; K Scott; D Scott; L B Travis; F E B May; J M Allan
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

8.  The deubiquitinating enzymes USP4 and USP17 target hyaluronan synthase 2 and differentially affect its function.

Authors:  M Mehić; V K de Sa; S Hebestreit; C-H Heldin; P Heldin
Journal:  Oncogenesis       Date:  2017-06-12       Impact factor: 7.485

9.  Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells.

Authors:  Albana Gattelli; Ivan Nalvarte; Anne Boulay; Tim C Roloff; Martin Schreiber; Neil Carragher; Kenneth K Macleod; Michaela Schlederer; Susanne Lienhard; Lukas Kenner; Maria I Torres-Arzayus; Nancy E Hynes
Journal:  EMBO Mol Med       Date:  2013-07-19       Impact factor: 12.137

10.  Efficient TGFβ-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2.

Authors:  H Porsch; B Bernert; M Mehić; A D Theocharis; C-H Heldin; P Heldin
Journal:  Oncogene       Date:  2012-10-29       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.